(Q33538424)

27 July 2017

1 reference

title

The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer (English)

1 reference

27 July 2017

1 reference

Gullick WJ

1

1 reference

27 July 2017

Srinivasan R

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Breast Cancer Research and Treatment

27 July 2017

1 reference

27 July 2017

52

1 reference

27 July 2017

1-3

1 reference

27 July 2017

43-53

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006107016969

27 July 2017

0 references

cites work

EGF and its receptor: historical perspective. Introduction

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

The cellular response to neuregulins is governed by complex interactions of the erbB receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Ligands for ErbB-family receptors encoded by a neuregulin-like gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

The structural basis for the specificity of epidermal growth factor and heregulin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Bivalence of EGF-like ligands drives the ErbB signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Inhibition of Drosophila EGF receptor activation by the secreted protein Argos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Human squamous cell lung cancers express increased epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Severe neuropathies in mice with targeted mutations in the ErbB3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Computer simulated evolution of a network of cell-signaling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

Role of the Juxtamembrane Domains of the Transforming Growth Factor-α Precursor and the β-Amyloid Precursor Protein in Regulated Ectodomain Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

A new model for the interaction of EGF-like ligands with their receptors: the new one-two

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

7 January 2021

Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

7 January 2021

Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

7 January 2021

c-erbB-3 protein expression in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006107016969

7 January 2021

Identifiers

DOI

10.1023/A:1006107016969

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference